TW350838B - Quinoline derivatives - Google Patents
Quinoline derivativesInfo
- Publication number
- TW350838B TW350838B TW084102060A TW84102060A TW350838B TW 350838 B TW350838 B TW 350838B TW 084102060 A TW084102060 A TW 084102060A TW 84102060 A TW84102060 A TW 84102060A TW 350838 B TW350838 B TW 350838B
- Authority
- TW
- Taiwan
- Prior art keywords
- alkyl
- alkoxy
- hydrogen
- heterocyclic group
- quinoline derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
- C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9404378A GB9404378D0 (en) | 1994-03-07 | 1994-03-07 | Quinoline derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
TW350838B true TW350838B (en) | 1999-01-21 |
Family
ID=10751426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW084102060A TW350838B (en) | 1994-03-07 | 1995-03-04 | Quinoline derivatives |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPH09509957A (fr) |
AU (1) | AU1823595A (fr) |
CA (1) | CA2214521A1 (fr) |
GB (1) | GB9404378D0 (fr) |
TW (1) | TW350838B (fr) |
WO (1) | WO1995024395A1 (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010032855A (ko) * | 1997-12-15 | 2001-04-25 | 후지야마 아키라 | Nkt 세포를 증강시키는 약제 |
SE9802550D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
US6133285A (en) | 1998-07-15 | 2000-10-17 | Active Biotech Ab | Quinoline derivatives |
US6121287A (en) * | 1998-07-15 | 2000-09-19 | Active Biotech Ab | Quinoline derivatives |
SE9802549D0 (sv) * | 1998-07-15 | 1998-07-15 | Active Biotech Ab | Quinoline derivatives |
RS51019B (sr) | 1999-10-25 | 2010-10-31 | Active Biotech Ab. | Lekovi za lečenje malignih tumora |
SE0002320D0 (sv) * | 1999-10-25 | 2000-06-21 | Active Biotech Ab | Malignant tumors |
TWI250023B (en) * | 2001-10-22 | 2006-03-01 | Santen Pharmaceutical Co Ltd | Pharmaceutical composition for itch treating agent |
JP2007191495A (ja) * | 2001-10-22 | 2007-08-02 | Santen Pharmaceut Co Ltd | 掻痒治療剤 |
AUPS058102A0 (en) | 2002-02-15 | 2002-03-14 | Fujisawa Pharmaceutical Co., Ltd. | Imidazole compounds |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52670B1 (en) * | 1981-03-03 | 1988-01-20 | Leo Ab | Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation |
SE8902076D0 (sv) * | 1989-06-09 | 1989-06-09 | Pharmacia Ab | Derivatives of quinoline-3-carboxanilide |
GB9108547D0 (en) * | 1991-04-22 | 1991-06-05 | Fujisawa Pharmaceutical Co | Quinoline derivatives |
TW222276B (fr) * | 1992-01-27 | 1994-04-11 | Fujisawa Pharmaceutical Co | |
GB9311562D0 (en) * | 1993-06-04 | 1993-07-21 | Fujisawa Pharmaceutical Co | Heterocyclic derivatives |
-
1994
- 1994-03-07 GB GB9404378A patent/GB9404378D0/en active Pending
-
1995
- 1995-02-22 CA CA002214521A patent/CA2214521A1/fr not_active Abandoned
- 1995-02-22 WO PCT/JP1995/000263 patent/WO1995024395A1/fr active Application Filing
- 1995-02-22 AU AU18235/95A patent/AU1823595A/en not_active Abandoned
- 1995-02-22 JP JP7523351A patent/JPH09509957A/ja active Pending
- 1995-03-04 TW TW084102060A patent/TW350838B/zh active
Also Published As
Publication number | Publication date |
---|---|
JPH09509957A (ja) | 1997-10-07 |
WO1995024395A1 (fr) | 1995-09-14 |
CA2214521A1 (fr) | 1995-09-14 |
GB9404378D0 (en) | 1994-04-20 |
AU1823595A (en) | 1995-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW282456B (fr) | ||
CA2107014A1 (fr) | Agent therapeutique pour la maladie de parkinson | |
GR3032516T3 (en) | Process for producing quinazoline derivatives | |
UY25679A1 (es) | Derivados de quinolin-2-ona inhibidores de la farnesil proteína transferasa útiles como agentes contra el cáncer | |
MX9800577A (es) | Derivados de 4,5-diaril oxazol. | |
LU88749I2 (fr) | TACRINE et ses dérivés pharmaceutiquement acceptables (COGNEX) | |
BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
NZ334954A (en) | Substituted heterocycles as anti-tumor agents | |
TW375615B (en) | Galanthamine derivatives and their use as medicaments | |
IT1250749B (it) | Composti eterociclici ad attivita' a ii antagonista | |
TW368501B (en) | 7-(2-aminoethyl)-benzothiazolones | |
NO953254L (no) | Substituerte azolonderivater for behandling av sykdommer forårsaket av helikobakter | |
TW350838B (en) | Quinoline derivatives | |
EP0774462A4 (fr) | Compose heterocyclique | |
EP0994106A4 (fr) | Procede de preparation de derives d'imidazole carbamoyles | |
ATE234818T1 (de) | Chinolinderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
HUT73172A (en) | 3`-aziridino-anthracycline derivatives, pharmaceutical compns. contg. the said compds, process to prepare them and their use | |
ES2016017A6 (es) | Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico. | |
DE60020130D1 (de) | Verfahren zur herstellung 3-amino-gallensaurer derivate | |
DE69813886D1 (de) | Naphthalin derivate | |
AU3285000A (en) | 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis | |
ES2206296T3 (es) | Derivados de tienopiranocarboxamida. | |
ES8707939A1 (es) | Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas | |
HUT65372A (en) | Propess for producing a therapeutic flavilium derivative | |
DE69310186T2 (de) | 1,2-dihydro-2-oxo-3-aminochinoxalin derivate, ihre verwendung als heilmittel |